[1]
N. R, S. K, B. Ing, T. K, and I. Pa, “EFFECTIVENESS AND TOXICITY DIFFERENCES BETWEEN THE USE OF REGIMEN CHEMOTHERAPY BLEOMYCIN-VINCRISTINE-MITOMYCIN-CISPLATIN AND BLEOMYCIN- VINCRISTINE-MITOMYCIN-CARBOPLATIN FOR THREE CYCLES IN PATIENTS CERVICAL CANCER SQUAMOUS CELL STADIUM IIB-IIIB IN SANGLAH GENERAL HOSPITAL DENPASAR BALI Research Article”, Asian J Pharm Clin Res, vol. 9, no. 8, pp. 149–153, Oct. 2016.